drugset / Trial / NCT03340701

Pharmacokinetics of Progesterone in Pregnancy

NCT03340701

Phase 1 Completed 6 enrolled Thomas Jefferson University
NaSingle-groupOpen-labelOther

Summary

Pharmacokinetic analysis of 200mg vaginal progesterone suppository in women with singleton pregnancies between 18 0/7- 23 6/7 weeks' gestation

Timeline

Start
2017-11-06
Primary completion
2018-06-30
Completion
2018-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Progesterone Other / unclassified 200 mg Other

Indications

No indication recorded.